Glenmark Life Sciences Stock Sees -5.02% Decline, MarketsMOJO Gives 'Hold' Call

Glenmark Life Sciences, a midcap pharmaceutical company, saw a decline of -5.02% in its stock on September 19, 2024. The stock has been on a downward trend for the past three days, with a consecutive fall of -8.06% during this period. This underperformance of -4.21% compared to the sector has led MarketsMOJO to give a 'Hold' call for the stock.

On the day of the decline, the stock touched an intraday low of Rs 1195.1, a decrease of -5.25%. However, the stock is still performing well in the long term, with its moving averages higher than the 20-day, 50-day, 100-day, and 200-day averages. The only exception is the 5-day moving average, which is lower.

In comparison to the Sensex, Glenmark Life Sciences' 1-day performance is -4.79%, while the Sensex has seen a positive performance of 0.23%. However, in the past month, the stock has outperformed the Sensex with a return of 20.62% compared to the Sensex's 3.37%.

Overall, Glenmark Life Sciences' stock has seen a recent decline but is still performing well in the long term. Investors should keep an eye on the stock's performance and consider the 'Hold' call given by MarketsMOJO before making any investment decisions.